Skip to main content

A Phase 3, Open-label Study Evaluating the Long-term Safety of VX-445 Combination Therapy in Subjects With Cystic Fibrosis

Open
  • Protocol code: VX18-445-113
  • EudraCT code: 2018-004652-38
  • Research group: Growth and Development
  • Service: Obstetrics
  • Principal investigator:  GARTNER TIZZANO, SILVIA
  • Phase: Fase III
  • Status: Recruiting volunteers